Goldman Sachs Group Inc Immunocore Holdings PLC Transaction History
Goldman Sachs Group Inc
- $580 Billion
- Q2 2024
A detailed history of Goldman Sachs Group Inc transactions in Immunocore Holdings PLC stock. As of the latest transaction made, Goldman Sachs Group Inc holds 90,184 shares of IMCR stock, worth $2.83 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
90,184
Previous 96,807
6.84%
Holding current value
$2.83 Million
Previous $6.29 Million
51.43%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding IMCR
# of Institutions
150Shares Held
39.8MCall Options Held
157KPut Options Held
135K-
Wellington Management Group LLP Boston, MA6.38MShares$200 Million0.04% of portfolio
-
Rtw Investments, LP New York, NY4.87MShares$153 Million2.76% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD2.99MShares$94 Million0.06% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.83MShares$88.9 Million0.01% of portfolio
-
Primecap Management CO Pasadena, CA1.95MShares$61.3 Million0.05% of portfolio
About Immunocore Holdings plc
- Ticker IMCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,897,100
- Market Cap $1.38B
- Description
- Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. Its other programs for oncology comprise IMC-C103C that is in ...